主要文件

查看所有文档

217042

4,4,4-三氟-1-苯基-1,3-丁二酮

Name: 4,4,4-三氟-1-苯基-1,3-丁二酮
Brand: ALDRICH

99%

别名:

BTA

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

C₆H₅COCH₂COCF₃

化学文摘社编号:

326-06-7

分子量:

216.16

NACRES:

NA.22

PubChem Substance ID:

24852988

UNSPSC Code:

12352100

EC Number:

206-307-8

MDL number:

MFCD00000425

Assay:

99%

Form:

solid

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

200

assay

99%

form

solid

bp

224 °C (lit.)

mp

38-40 °C (lit.)

solubility

95% ethanol: soluble 25 mg/mL, clear, colorless to yellow

functional group

fluoro, ketone, phenyl

SMILES string

FC(F)(F)C(=O)CC(=O)c1ccccc1

InChI

1S/C10H7F3O2/c11-10(12,13)9(15)6-8(14)7-4-2-1-3-5-7/h1-5H,6H2

InChI key

VVXLFFIFNVKFBD-UHFFFAOYSA-N

说明

Application

4,4,4-三氟-1-苯基-1,3-丁二酮通过席夫碱缩合反应合成了一系列三氟甲基取代的 NNO 酮亚胺。它还被用于混合配体螯合萃取三价镧系元素和作为配体制备三元镧系元素 (Ln) 配合物。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

210.2 °F - closed cup

flash_point_c

99 °C - closed cup

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Infrapopliteal Anatomic Severity and Delayed Wound Healing in Patients With Chronic Limb-Threatening Ischemia in the Era of the Global Limb Anatomic Staging System.

Yosuke Hata et al.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 27(4), 641-646 (2020-06-24)

Purpose: To investigate the prognostic impact of infrapopliteal (IP) artery anatomic severity according to the Global Limb Anatomic Staging System (GLASS) on delayed wound healing in patients with chronic limb-threatening ischemia (CLTI). Materials and Methods: This study retrospectively analyzed 639

Syntheses, crystal structures, visible and near-IR luminescent properties of ternary lanthanide (Dy³⁺, Tm³⁺) complexes containing 4, 4, 4-trifluoro-1-phenyl-1, 3-butanedione and 1, 10-phenanthroline.

Feng J, et al.

Journal of Luminescence, 128(12), 1957-1964 (2008)

Mechanical dilation, botulinum toxin A injection, and surgical myotomy with fundoplication for treatment of lower esophageal sphincter achalasia-like syndrome in dogs.

M E Grobman et al.

Journal of veterinary internal medicine, 33(3), 1423-1433 (2019-04-11)

Megaesophagus (ME) carries a poor long-term prognosis in dogs. In people, lower esophageal sphincter (LES) achalasia is a rare cause of ME that may respond to targeted intervention. Dogs with lower esophageal sphincter achalasia-like syndrome (LES-AS) have been described recently

查看所有相关文献

全球贸易项目编号

货号	GTIN
217042-25G	04061838774705